Nasal Type Extranodal NK/T-Cell Lymphoma

Nasal Type Extranodal NK/T-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

146 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 16%
Top sponsor: Ruijin Hospital
Termination share: 31.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03999658	A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies	withdrawn	Phase 2	0	Sorrento Therapeutics, Inc.INDUSTRY	0	May 1, 2023	clinicaltrials
NCT01652014	Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies	withdrawn	Phase 2	0	University of Medicine and Dentistry of New JerseyOTHER	1	Jul 14, 2016